In China, a Detention and a New Espionage Law Have Businesses Worried



BEIJING—Hiroshi Nishiyama, a veteran Japanese executive at Astellas Pharma Inc. and a prominent member of his country’s business circle in China, spent late March wrapping up his assignment there and preparing to head home.

He never made it. Mr. Nishiyama disappeared on what was supposed to be his last day in China. A few days later, China’s Foreign Ministry said he had been accused of espionage and detained.



BEIJING—Hiroshi Nishiyama, a veteran Japanese executive at Astellas Pharma Inc. and a prominent member of his country’s business circle in China, spent late March wrapping up his assignment there and preparing to head home.

He never made it. Mr. Nishiyama disappeared on what was supposed to be his last day in China. A few days later, China’s Foreign Ministry said he had been accused of espionage and detained.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@technoblender.com. The content will be deleted within 24 hours.
4503.TOAccountingAccounting/ConsultingAstellas PharmaBusinessBusiness Consultancybusiness newsBusiness/Consumer ServicesBusinessesC&E Industry News Filterchinaconsultingconsumer servicesContent TypescorporateCorporate/Industrial NewsdetentionEconomyespionageFactiva FiltersFinancial Servicesgeneral newsgovernment policyhealthcareHealthcare/Life SciencesHiroshi Nishiyamaindustrial newsinternational relationsJP:4503Lawlife sciencesMarketNationalNational/Public SecurityPharmaceuticalspoliticalPolitical/General NewspoliticsPolitics/International Relationspublic securityregulationRegulation/Government PolicyRisk Management ServicesSYNDworriedWSJ-PRO-WSJ.com
Comments (0)
Add Comment